Identification of a 100-kb region of common allelic loss on chromosome bands 10q25-q26 in human endometrial cancer. 1998

H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan.

In human endometrial cancer, we have previously identified a 790-kb region of common allelic loss in chromosome bands 10q25-q26, flanked by D10S587 and D10S1723. We constructed a contig covering the entire deleted region using YACs, PACs, and BACs. Five overlapping cosmid clones derived from YAC clones completely covered the entire deleted region: its size was estimated to be no larger than 200 kb. We further performed two-color fluorescence in situ hybridization (FISH) analysis to confirm the deletion and narrowed down the deleted region to 100 kb or less; it was covered by three overlapping cosmid clones that were included in one BAC clone. Restriction endonuclease mapping identified a region in which NotI, SalI, SmaI, and Xhol were clustered, suggesting the possible existence of a CpG island.

UI MeSH Term Description Entries
D002871 Chromosome Banding Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping. Banding, Chromosome,Bandings, Chromosome,Chromosome Bandings
D002873 Chromosome Fragility Susceptibility of chromosomes to breakage leading to translocation; CHROMOSOME INVERSION; SEQUENCE DELETION; or other CHROMOSOME BREAKAGE related aberrations. Chromosomal Fragility,Fragility, Chromosomal,Fragility, Chromosome
D002879 Chromosomes, Human, Pair 10 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 10
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015183 Restriction Mapping Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA. Endonuclease Mapping, Restriction,Enzyme Mapping, Restriction,Site Mapping, Restriction,Analysis, Restriction Enzyme,Enzyme Analysis, Restriction,Restriction Enzyme Analysis,Analyses, Restriction Enzyme,Endonuclease Mappings, Restriction,Enzyme Analyses, Restriction,Enzyme Mappings, Restriction,Mapping, Restriction,Mapping, Restriction Endonuclease,Mapping, Restriction Enzyme,Mapping, Restriction Site,Mappings, Restriction,Mappings, Restriction Endonuclease,Mappings, Restriction Enzyme,Mappings, Restriction Site,Restriction Endonuclease Mapping,Restriction Endonuclease Mappings,Restriction Enzyme Analyses,Restriction Enzyme Mapping,Restriction Enzyme Mappings,Restriction Mappings,Restriction Site Mapping,Restriction Site Mappings,Site Mappings, Restriction
D016889 Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. Cancer of Endometrium,Endometrial Cancer,Endometrial Carcinoma,Cancer of the Endometrium,Carcinoma of Endometrium,Endometrium Cancer,Neoplasms, Endometrial,Cancer, Endometrial,Cancer, Endometrium,Cancers, Endometrial,Cancers, Endometrium,Carcinoma, Endometrial,Carcinomas, Endometrial,Endometrial Cancers,Endometrial Carcinomas,Endometrial Neoplasm,Endometrium Cancers,Endometrium Carcinoma,Endometrium Carcinomas,Neoplasm, Endometrial
D017404 In Situ Hybridization, Fluorescence A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. FISH Technique,Fluorescent in Situ Hybridization,Hybridization in Situ, Fluorescence,FISH Technic,Hybridization in Situ, Fluorescent,In Situ Hybridization, Fluorescent,FISH Technics,FISH Techniques,Technic, FISH,Technics, FISH,Technique, FISH,Techniques, FISH
D018244 Chromosomes, Artificial, Yeast Chromosomes in which fragments of exogenous DNA ranging in length up to several hundred kilobase pairs have been cloned into yeast through ligation to vector sequences. These artificial chromosomes are used extensively in molecular biology for the construction of comprehensive genomic libraries of higher organisms. Artificial Chromosomes, Yeast,Yeast Artificial Chromosomes,Chromosomes, Yeast Artificial,YAC (Chromosome),YACs (Chromosomes),Artificial Chromosome, Yeast,Chromosome, Yeast Artificial,Yeast Artificial Chromosome

Related Publications

H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
May 1998, Genes, chromosomes & cancer,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
December 1996, British journal of cancer,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
July 1998, Cancer genetics and cytogenetics,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
April 2004, Human mutation,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
September 1998, Genes, chromosomes & cancer,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
June 1995, Oncogene,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
June 1998, Cancer research,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
October 1996, Genes, chromosomes & cancer,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
December 2000, Medical and pediatric oncology,
H Yamakawa, and S Nagase, and M Yuki, and H O Shiwaku, and T Furukawa, and K Yoshinaga, and E Soeda, and M Hoshi, and Y Hayashi, and S Sato, and A Yajima, and A Horii
April 1993, International journal of cancer,
Copied contents to your clipboard!